Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07796048

Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism

1. Background and Rationale: Primary aldosteronism is a hypertension-related disorder where salt restriction/salt loss is a central part of therapy. Dietary salt restriction to sufficient degree is very difficult for most patients and thus medications are frequently required to control blood pressure. Non-pharmacologic means of reducing total body sodium and blood pressure are required and desired by patients. Sauna bathing is a traditional wellness practice associated with extensive sweating and therefore salt loss. We wish to study whether incorporation of sauna bathing into a treatment plan for primary aldosteronism might lower blood pressure without increased medications. A pilot feasibility study is required prior to design of a larger controlled clinical trial. We are looking to conduct a short term simulated sauna study to assess patient acceptability and study feasibility as the primary outcomes. 2. Research Questions and Objectives: This study will test the feasibility of having patients add regular sauna usage to their weekly lifestyle, while being treated for hypertension due to primary aldosteronism. The primary objective will be to assess patient recruitment rates, subject retention, patient acceptability, and patient adherence to regular sauna intervention during a 2-week period, using an a priori "traffic light" decision matrix. The secondary objectives will be to explore change in blood pressure, as measured by a wearable, continuous BP wrist monitor, before and after a 2 week sauna intervention. 3. Methods: The study will occur in the context of routine ongoing care in the Endocrine Hypertension Clinic. Ten patients with primary aldosteronism will be recruited to a 7 week study where we will observe the feasibility and acceptability of wearing a continuous, cuffless, wrist BP monitoring device for 2-week periods prior to, during, and after a 2 week "sauna" therapy program. The sauna therapy will consist of three 30 minute visits to a commercially licensed and insured local sauna club each week for 2 weeks. Standardized subject experience questionnaires will collect feasibility and acceptability data which will be analyzed with a standard red light/yellow light/green light approach to study feasibility conclusions.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a) Age 18-65 b) Hypertension with PA diagnosed using Endocrine Society's 2025 criteria c) Stable medical therapy with no change in dose/agent in prior 6 weeks d) BP uncontrolled, clinic > 140/90 or ABPM mean > 135/85 e) Dietary sodium moderate or higher (> 128 mmol/d) f) Subject owns iPhone (12-16) or Android and willing to install HiLo app

Exclusion criteria

  • BP > 160/105 in clinic or > 155/100 on ABPM
  • Planning adrenalectomy or other surgery during trial
  • Recent hospitalization for any reason, in the past 3 months
  • Confirmed or suspected MI, angina, CHF or arrhythmia diagnosis in the past 6 months
  • CKD, eGFR < 30 ml/min/m2
  • Pregnancy, planned pregnancy, or non-use of contraceptive during study
  • Recent hypotensive event/syncope in the past 3 months
  • Any complex medical condition where sauna exposure is not advised
  • Planning major dietary change
  • History of medication non-adherence
  • Night shift worker / at work after 2000h
  • Planned vacation/absence during 6-week study
  • Inability to read English or consent to participation

Treatment and study plan

sauna session

Behavioral

thrice-weekly, 30-minute sauna session for 2 weeks

Primary outcomes

  1. approach-to-consent ratio

    Time frame: from study initiation to end of recruitment window 52 weeks later

    Calculated ratio of subjects approached for recruitment vs number agreed to participate

  2. Mean monthly enrolment rate

    Time frame: within 6 months of study initiation

    Number of subjects enrolled per month from study opening

  3. Drop out rate

    Time frame: from subject enrolment to intervention completion 7 weeks later.

    Percentage of subjects who do not complete the 7 week sauna study after enrolment.

  4. HILO BP monitor wearability

    Time frame: From enrolment to intervention completion, 7 weeks.

    Number of hours of data recorded showing % of time the HILO monitor was worn during the 7 week study.

  5. Score on the Acceptability of Intervention Measure

    Time frame: from enrolment to study intervention completion, 7 weeks.

    Mean score (/20) on the patient-scoring system Acceptability of Intervention Measure

  6. Sauna Usability

    Time frame: 2 weeks of sauna intervention phase

    Proportion of subjects attending 4 or more of the 6 scheduled sauna sessions

Secondary outcomes

  1. 24 hour mean blood pressure

    Time frame: 3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.

    24 hour mean blood pressure from HILO monitoring data

  2. Daytime mean blood pressure

    Time frame: 3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.

    Daytime (0700-2300) mean BP from HILO monitor

  3. Nighttime mean blood pressure

    Time frame: 3 time frames: first two weeks of run-in, two weeks of intervention, two weeks of run-out.

    Mean BP (2300-0700) from HILO BP monitor device

Study contacts

Contact information is provided by the study sponsor or research team.

Gregory Kline, MD

CONTACT

[email protected]

403-955-8327

Sponsors and collaborators

Lead sponsor

University of Calgary

Other

Registry information

Official study title

Sauna as an Adjunct to Usual Medical Therapy for Non-reNAl Sodium Elimination in Primary Aldosteronism: Pilot Study (SAUNA-PA)

Acronym: SAUNA-PA

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Aug 31, 2026
Registry last updated
Aug 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.